"公立医院医改是关乎民生福祉、行业发展的重要工作，而医改政策的精准解读与落地，直接影响着公 立医院的良性运转、医疗服务质量的提升以及群众就医获得感的增强。"李振玉在致辞时表示，医疗卫 生服务价格分会作为连接协会与医疗卫生领域的重要纽带，此次聚焦医改政策开展分享交流，不仅为大 中国发展网讯11月16日，以"向新、向质、向未来"为主题的公立医院医改政策暨DRG/DIP、立项指南政 策分享会在济南举办。此次分享会邀请了医保、卫健和医院等领域的相关专家和一线工作人员，大家打 破壁垒，共同探讨公立医院的改革与发展之路，深入畅谈DRG/DIP、立项指南医改政策分享、医学检验 赋能等举措如何助力医院改革、提升服务质量。 本次分享会由山东省价格协会医疗卫生服务价格分会主办。省价格协会会长李振玉出席会议并致辞，山 东第一医科大学第一附属医院山东省千佛山医院院长田辉也以视频形式发布致辞，中华医学会检验分会 主任委员、山东大学检验医学创新技术研究院院长王传新在现场发表了致辞。 家搭建了学习研讨的平台，更能帮助大家准确把握政策导向、破解实践难题，意义重大。一直以来，山 东省价格协会始终高度关注医疗卫生服务价格领域的发展，也全力支持分 ...

Core Points - The National Healthcare Security Administration (NHSA) has released a guideline for the pricing of medical services related to the vascular and lymphatic systems, consolidating existing pricing projects into 116 items, with an additional 9 surcharge items and 1 expansion item [1] - The guideline aims to standardize medical service pricing projects to improve pricing accuracy, execution, and evaluation, aligning with clinical diagnosis and treatment needs [1] - Pricing projects are categorized based on vascular differences, with specific pricing for various types of arteries and corresponding stent placement fees, enhancing compatibility of pricing projects [1] - The guideline supports the clinical application of new products and technologies, such as vascular protection devices, which are crucial for preventing serious complications during vascular surgeries [2] - The NHSA will expedite the implementation of the pricing guideline across provinces, ensuring that pricing levels are reasonable and sustainable for patients, healthcare institutions, and insurance funds [2]

Core Insights - The National Healthcare Security Administration (NHSA) has issued guidelines for pricing projects related to digestive system medical services and hernia and thyroid surgeries, aiming to enhance diagnostic quality and standardize pricing practices [1] Group 1: Standardization of Pricing - The guidelines integrate existing projects to promote standardized pricing, addressing the complexity of the digestive system and its treatments [2] - A new unified pricing unit for "gastrointestinal pressure measurement" has been established, allowing for multiple pressure tests to be charged under one fee, enhancing compatibility of diagnostic and treatment projects [2] Group 2: Transparency in Charges - The guidelines clarify the pricing for lymph node dissection, which is often performed alongside other treatments, to reduce billing disputes [3] - For example, the pricing structure for colon cancer treatment now distinctly separates charges for partial colon resection, extensive radical resection, and abdominal lymph node dissection, providing clear billing guidance [3] Group 3: Differentiation of Surgical Complexity - The guidelines categorize hernia surgeries into "routine" and "complex" based on surgical difficulty, reflecting clinical value [4] - Specific cases, such as large hernias or those requiring significant surgical intervention, are classified under complex hernia repair fees, allowing for a more nuanced pricing approach [4] - The classification system also applies to thyroid surgeries, where individual patient anatomy may increase surgical difficulty, ensuring appropriate pricing standards are established [4]

Group 1: Policy Initiatives - The National Healthcare Security Administration (NHSA) is focusing on technological innovation in the medical field, introducing a series of forward-looking pricing projects to support high-level innovations [1][4] - NHSA has released 27 batches of project guidelines, adding over 100 pricing items related to new products and devices [1] - A dynamic response mechanism has accelerated the implementation of policies, allowing for rapid local execution of pricing adjustments [2] Group 2: Specific Innovations and Pricing - In the field of artificial hearts, NHSA has introduced pricing for implantation, extraction, and adjustment services, reducing the overall cost of artificial heart surgeries from over 1 million yuan to around 700,000 yuan [1] - For cochlear implants, the NHSA has standardized the implantation fee to 3,500 yuan, significantly lowering the cost from over 200,000 yuan to 50,000 yuan [2] - New pricing projects for proton therapy, heavy ion therapy, and boron neutron capture therapy have been established to support cancer treatment advancements [2][3] Group 3: Market Impact and Future Directions - The NHSA aims to create a virtuous cycle of high-quality innovation leading to reasonable returns and continuous innovation in the healthcare sector [2] - The introduction of differentiated pricing for invasive and non-invasive brain-machine interfaces encourages companies to focus on niche markets, avoiding redundant competition [3] - NHSA is committed to maintaining an open attitude towards high-level new technology pricing, facilitating the rapid entry of innovative results into clinical practice [4]